Evidence map›Paper›PMID 29089533›Full record

ArticleScientific reports2017

Proton minibeam radiation therapy spares normal rat brain: Long-Term Clinical, Radiological and Histopathological Analysis.

Yolanda Prezado, Gregory Jouvion, David Hardy, Annalisa Patriarca, Catherine Nauraye, Judith Bergs, Wilfredo González, Consuelo Guardiola, Marjorie Juchaux, Dalila Labiod and 4 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 127 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Yolanda PrezadoLaboratoire d'Imagerie et Modélisation en Neurobiologie et Cancérologie (IMNC), Centre National de la Recherche Scientifique (CNRS); Universités Paris 11 and Paris 7, Campus d'Orsay, 91405, Orsay, France. prezado@imnc.in2p3.fr.
Gregory JouvionInstitut Pasteur, Histopathologie Humaine et Modèles Animaux, Institut Pasteur, 28 Rue du Docteur Roux, 75015, Paris, France.
David HardyInstitut Pasteur, Histopathologie Humaine et Modèles Animaux, Institut Pasteur, 28 Rue du Docteur Roux, 75015, Paris, France.
Annalisa PatriarcaInstitut Curie - Centre de Protonthérapie d'Orsay, Campus Universitaire, Bât. 101, Orsay, 91898, France.
Catherine NaurayeInstitut Curie - Centre de Protonthérapie d'Orsay, Campus Universitaire, Bât. 101, Orsay, 91898, France.
Judith BergsLaboratoire d'Imagerie et Modélisation en Neurobiologie et Cancérologie (IMNC), Centre National de la Recherche Scientifique (CNRS); Universités Paris 11 and Paris 7, Campus d'Orsay, 91405, Orsay, France.
Wilfredo GonzálezLaboratoire d'Imagerie et Modélisation en Neurobiologie et Cancérologie (IMNC), Centre National de la Recherche Scientifique (CNRS); Universités Paris 11 and Paris 7, Campus d'Orsay, 91405, Orsay, France.
Consuelo GuardiolaLaboratoire d'Imagerie et Modélisation en Neurobiologie et Cancérologie (IMNC), Centre National de la Recherche Scientifique (CNRS); Universités Paris 11 and Paris 7, Campus d'Orsay, 91405, Orsay, France.
Marjorie JuchauxLaboratoire d'Imagerie et Modélisation en Neurobiologie et Cancérologie (IMNC), Centre National de la Recherche Scientifique (CNRS); Universités Paris 11 and Paris 7, Campus d'Orsay, 91405, Orsay, France.
Dalila LabiodInstitut Curie, PSL Research University, Translational Research Department, Experimental Radiotherapy Platform, Orsay, France.
Remi DendaleInstitut Curie - Centre de Protonthérapie d'Orsay, Campus Universitaire, Bât. 101, Orsay, 91898, France.
Laurène JourdainImagerie par Résonance Magnétique Médicale et Multi-modalités (IR4M-UMR8081), Université Paris Sud, 91405, Orsay, France.
Catherine SebrieImagerie par Résonance Magnétique Médicale et Multi-modalités (IR4M-UMR8081), Université Paris Sud, 91405, Orsay, France.
Frederic PouzouletInstitut Curie, PSL Research University, Translational Research Department, Experimental Radiotherapy Platform, Orsay, France.
Centre National de la Recherche Scientifique · FRInstitut Curie · FRInstitut Pasteur · FRUniversité Paris-Saclay · FRImagerie par Résonance Magnétique Médicale et Multi-Modalités · FRUniversité Paris Sciences et Lettres · FRUniversité Paris-Sud · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proton minibeam radiation therapy (pMBRT) is a novel strategy for minimizing normal tissue damage resulting from radiotherapy treatments. This strategy partners the inherent advantages of protons for radiotherapy with the gain in normal tissue preservation observed upon irradiation with narrow, spatially fractionated beams. In this study, whole brains (excluding the olfactory bulb) of Fischer 344 rats (n = 16) were irradiated at the Orsay Proton Therapy Center. Half of the animals received standard proton irradiation, while the other half were irradiated with pMBRT at the same average dose (25 Gy in one fraction). The animals were followed-up for 6 months. A magnetic resonance imaging (MRI) study using a 7-T small-animal MRI scanner was performed along with a histological analysis. Rats treated with conventional proton irradiation exhibited severe moist desquamation, permanent epilation and substantial brain damage. In contrast, rats in the pMBRT group exhibited no skin damage, reversible epilation and significantly reduced brain damage; some brain damage was observed in only one out of the eight irradiated rats. These results demonstrate that pMBRT leads to an increase in normal tissue resistance. This net gain in normal tissue sparing can lead to the efficient treatment of very radio-resistant tumours, which are currently mostly treated palliatively.

Indexed as

AnimalsAstrocytesBrainBrain NeoplasmsCranial IrradiationFollow-Up StudiesMagnetic Resonance ImagingMicrogliaProton TherapyRadiation InjuriesRadiotherapy DosageRats, Inbred F344

Identifiers

PMID29089533
PMCPMC5663851
OpenAlexW2766619605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.